224 related articles for article (PubMed ID: 38064524)
1. The V2 domain of HIV gp120 mimics an interaction between CD4 and integrin ⍺4β7.
Van Ryk D; Vimonpatranon S; Hiatt J; Ganesan S; Chen N; McMurry J; Garba S; Min S; Goes LR; Girard A; Yolitz J; Licavoli I; Wei D; Huang D; Soares MA; Martinelli E; Cicala C; Arthos J
PLoS Pathog; 2023 Dec; 19(12):e1011860. PubMed ID: 38064524
[TBL] [Abstract][Full Text] [Related]
2. A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion.
Truneh A; Buck D; Cassatt DR; Juszczak R; Kassis S; Ryu SE; Healey D; Sweet R; Sattentau Q
J Biol Chem; 1991 Mar; 266(9):5942-8. PubMed ID: 1706342
[TBL] [Abstract][Full Text] [Related]
3. The V2 loop of HIV gp120 delivers costimulatory signals to CD4
Goes LR; Sajani A; Sivro A; Olowojesiku R; Ray JC; Perrone I; Yolitz J; Girard A; Leyre L; Wibmer CK; Morris L; Gorini G; Franchini G; Mason RD; Roederer M; Mehandru S; Soares MA; Cicala C; Fauci AS; Arthos J
Proc Natl Acad Sci U S A; 2020 Dec; 117(51):32566-32573. PubMed ID: 33288704
[TBL] [Abstract][Full Text] [Related]
4. Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7.
Lertjuthaporn S; Cicala C; Van Ryk D; Liu M; Yolitz J; Wei D; Nawaz F; Doyle A; Horowitch B; Park C; Lu S; Lou Y; Wang S; Pan R; Jiang X; Villinger F; Byrareddy SN; Santangelo PJ; Morris L; Wibmer CK; Biris K; Mason RD; Gorman J; Hiatt J; Martinelli E; Roederer M; Fujikawa D; Gorini G; Franchini G; Arakelyan A; Ansari AA; Pattanapanyasat K; Kong XP; Fauci AS; Arthos J
PLoS Pathog; 2018 Aug; 14(8):e1007278. PubMed ID: 30153309
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Matrix Proteins Mediate HIV-1 gp120 Interactions with α
Plotnik D; Guo W; Cleveland B; von Haller P; Eng JK; Guttman M; Lee KK; Arthos J; Hu SL
J Virol; 2017 Nov; 91(21):. PubMed ID: 28814519
[TBL] [Abstract][Full Text] [Related]
6. The HIV-1 Env gp120 Inner Domain Shapes the Phe43 Cavity and the CD4 Binding Site.
Prévost J; Tolbert WD; Medjahed H; Sherburn RT; Madani N; Zoubchenok D; Gendron-Lepage G; Gaffney AE; Grenier MC; Kirk S; Vergara N; Han C; Mann BT; Chénine AL; Ahmed A; Chaiken I; Kirchhoff F; Hahn BH; Haim H; Abrams CF; Smith AB; Sodroski J; Pazgier M; Finzi A
mBio; 2020 May; 11(3):. PubMed ID: 32457241
[TBL] [Abstract][Full Text] [Related]
7. Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor.
Peachman KK; Karasavvas N; Chenine AL; McLinden R; Rerks-Ngarm S; Jaranit K; Nitayaphan S; Pitisuttithum P; Tovanabutra S; Zolla-Pazner S; Michael NL; Kim JH; Alving CR; Rao M
PLoS One; 2015; 10(12):e0143895. PubMed ID: 26625359
[TBL] [Abstract][Full Text] [Related]
8. The Role of Integrin α
Kasarpalkar N; Deb B; Kumar P; Bhor VM
OMICS; 2020 Jul; 24(7):437-450. PubMed ID: 32522079
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV.
Cicala C; Arthos J; Fauci AS
J Transl Med; 2011 Jan; 9 Suppl 1(Suppl 1):S2. PubMed ID: 21284901
[TBL] [Abstract][Full Text] [Related]
10. Beta-turn Phe in HIV-1 Env binding site of CD4 and CD4 mimetic miniprotein enhances Env binding affinity but is not required for activation of co-receptor/17b site.
Dowd CS; Leavitt S; Babcock G; Godillot AP; Van Ryk D; Canziani GA; Sodroski J; Freire E; Chaiken IM
Biochemistry; 2002 Jun; 41(22):7038-46. PubMed ID: 12033937
[TBL] [Abstract][Full Text] [Related]
11. Conformational and structural features of HIV-1 gp120 underlying the dual receptor antagonism by cross-reactive neutralizing antibody m18.
Gift SK; Zentner IJ; Schön A; McFadden K; Umashankara M; Rajagopal S; Contarino M; Duffy C; Courter JR; Zhang MY; Gershoni JM; Cocklin S; Dimitrov DS; Smith AB; Freire E; Chaiken IM
Biochemistry; 2011 Apr; 50(14):2756-68. PubMed ID: 21351734
[TBL] [Abstract][Full Text] [Related]
12. Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4.
Yang QE; Stephen AG; Adelsberger JW; Roberts PE; Zhu W; Currens MJ; Feng Y; Crise BJ; Gorelick RJ; Rein AR; Fisher RJ; Shoemaker RH; Sei S
J Virol; 2005 May; 79(10):6122-33. PubMed ID: 15857997
[TBL] [Abstract][Full Text] [Related]
13. Species-Specific Valid Ternary Interactions of HIV-1 Env-gp120, CD4, and CCR5 as Revealed by an Adaptive Single-Amino Acid Substitution at the V3 Loop Tip.
Koma T; Yokoyama M; Kotani O; Doi N; Nakanishi N; Okubo H; Adachi S; Adachi A; Sato H; Nomaguchi M
J Virol; 2021 Jun; 95(13):e0217720. PubMed ID: 33883222
[TBL] [Abstract][Full Text] [Related]
14. MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency.
Grupping K; Selhorst P; Michiels J; Vereecken K; Heyndrickx L; Kessler P; Vanham G; Martin L; Ariën KK
Retrovirology; 2012 May; 9():36. PubMed ID: 22551420
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus gp120 binding C'C" ridge of CD4 domain 1 is also involved in interaction with class II major histocompatibility complex molecules.
Moebius U; Clayton LK; Abraham S; Diener A; Yunis JJ; Harrison SC; Reinherz EL
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12008-12. PubMed ID: 1465431
[TBL] [Abstract][Full Text] [Related]
16. Histidine 375 Modulates CD4 Binding in HIV-1 CRF01_AE Envelope Glycoproteins.
Zoubchenok D; Veillette M; Prévost J; Sanders-Buell E; Wagh K; Korber B; Chenine AL; Finzi A
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928014
[TBL] [Abstract][Full Text] [Related]
17. Identification and structural analysis of residues in the V1 region of CD4 involved in interaction with human immunodeficiency virus envelope glycoprotein gp120 and class II major histocompatibility complex molecules.
Bowman MR; MacFerrin KD; Schreiber SL; Burakoff SJ
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):9052-6. PubMed ID: 1978941
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells.
Arthos J; Cicala C; Martinelli E; Macleod K; Van Ryk D; Wei D; Xiao Z; Veenstra TD; Conrad TP; Lempicki RA; McLaughlin S; Pascuccio M; Gopaul R; McNally J; Cruz CC; Censoplano N; Chung E; Reitano KN; Kottilil S; Goode DJ; Fauci AS
Nat Immunol; 2008 Mar; 9(3):301-9. PubMed ID: 18264102
[TBL] [Abstract][Full Text] [Related]
19. The human immunodeficiency virus gp120 binding site on CD4: delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure.
Moebius U; Clayton LK; Abraham S; Harrison SC; Reinherz EL
J Exp Med; 1992 Aug; 176(2):507-17. PubMed ID: 1500858
[TBL] [Abstract][Full Text] [Related]
20. CD4-derived synthetic peptide blocks the binding of HIV-1 GP120 to CD4-bearing cells and prevents HIV-1 infection.
Shapira-Nahor O; Golding H; Vujcic LK; Resto-Ruiz S; Fields RL; Robey FA
Cell Immunol; 1990 Jun; 128(1):101-17. PubMed ID: 1971526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
